MW 478.5 Da, Purity >98%. Potent, selective PPARα agonist (EC50 = 4 nM). Increases HDL cholesterol, decreases LDL and VLDL cholesterol. Reduces triglycerides. Shows antidyslipidemic effects in vivo..
View Alternative Names
FAAR, MGC2237, MGC2452, MGC3931, NR1C1, NR1C2, NUC1, NUCI, NUCII, Nuclear hormone receptor 1, Nuclear receptor subfamily 1 group C member 1, Nuclear receptor subfamily 1 group C member 2, OTTHUMP00000197740, OTTHUMP00000197741, PPAR, PPAR-alpha, PPAR-beta, PPAR-delta, PPAR-鑴, PPARA_HUMAN, PPARB, PPARD_HUMAN, Peroxisome proliferative activated receptor alpha, Peroxisome proliferative activated receptor delta, Peroxisome proliferator-activated receptor alpha, Peroxisome proliferator-activated receptor beta, Peroxisome proliferator-activated receptor beta (PPAR-beta), Peroxisome proliferator-activated receptor delta, hPPAR
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com